
    
      This single centre, randomized, controlled, examiner-blind, 2 treatment arm, parallel group
      design study, stratified by maximum baseline Schiff sensitivity score (of the two selected
      teeth), with a treatment period of 8 weeks will investigate the clinical effectiveness of an
      experimental stannous fluoride dentifrice in the reduction of DH. DH will be assessed at
      Baseline, and after 4 and 8 weeks treatment to monitor clinical efficacy and safety.
    
  